Oncolytics Biotech Research Centres
Research centre seeking to maximize the impact of neuroscience and establish Ontario as a world leader in brain research, commercialization and care.
Industry:
PharmTech
Investors Number:
4
Technology:
Cancer
Last Funding Type:
Post-IPO Equity
Headquarters:
Canada
Founded Date:
1988
Investor Type:
For Profit
Funding Status:
IPO
Total Funding:
$24M
Estimated Revenue:
$1M to $10M
Employee Number:
11-50